The amount was up more than 31 percent compared with the first half of 2016.
More than 300 industry leaders attended this year’s meeting.
Mobius president is fighting a bill that would loosen FDA oversight, as doctors push for its passage.
The move follows BVI’s purchase of Malosa Medical in April.
The company’s technology served as the basis for Alcon’s Verion system.
The FDA found deficiencies in manufacturing processes and analytical testing during an inspection in May.
A majority of patients were maintained on a 12-week dosing interval immediately following the loading phase through week 48.
The company is hoping for US approval by 2019.
The move would bring the agency closer to industry, which has embraced the use of algorithmic science.
The agency said it will update the list every six months.
ASCs would receive a 1.9 percent inflation update, on average, in 2018, according to analysis by OOSS.
Alcon and Allergan are the market leaders; dozens of companies compete in the segment.
MIGS implants will account for most of the growth over the next five years.
We asked surgeons what policies they would support related to drug pricing, as well as their plans for an EDOF ICL, if it becomes available.
The company said it plans to seek the added labeling in Europe within eight months.
You are not currently logged in.
©2017 Market Scope
Lost your Password